Comparative Efficacy and Safety of Endovascular vs. Surgical Treatment in Spinal Dural Arteriovenous Fistulas

医学 外科 血管内治疗 动静脉瘘 闭塞 椎动脉 瘘管 动脉瘤
作者
Basel Musmar,Joanna M. Roy,Atakan Orscelik,Sonu Bhaskar,Saman Sizdahkhani,Elias Atallah,Sravanthi Koduri,Stavropoula Tjoumakaris,M. Reid Gooch,Robert H. Rosenwasser,Fadi Al Saiegh
出处
期刊:Spine [Lippincott Williams & Wilkins]
标识
DOI:10.1097/brs.0000000000005226
摘要

Systematic Review and Meta-analysis. This study aims to compare the efficacy and safety of surgical and endovascular treatments for SDAVFs. Spinal dural arteriovenous fistulas (SDAVFs) result from an abnormal connection between the radiculomeningeal artery and the radicular vein, leading to venous hypertension and potential neurological damage. The two primary treatment strategies are surgical closure and endovascular obliteration of the fistula. PubMed, Scopus, and Web of Science databases were searched from inception to July 2024. We defined the successful treatment as fistula occlusion with sufficient embolic material penetration or obliteration during surgery. A total of 1192 articles were identified, with 40 studies meeting the inclusion criteria, comprising 1818 patients (surgical: 804, endovascular: 1014). The surgical group demonstrated higher rates of complete occlusion at last follow-up (96.8%, 363/375) compared to the endovascular group (72.5%, 470/648) (OR: 0.16; CI: 0.09 to 0.28, P<0.01). Surgical treatment also had higher successful treatment rates (97.5%, 392/402) compared to endovascular treatment (66.7%, 529/793) (OR: 0.11; CI: 0.06 to 0.19, P<0.01). Recurrence rates were lower in the surgical group (OR: 6.04; CI: 3.45 to 10.57, P<0.01) and retreatment rates were also lower (OR: 7.16; CI: 4.11 to 12.48, P<0.01). Initial treatment failure was significantly higher in the endovascular group (32.2%, 329/1023) compared to the surgical group (2.3%, 19/804) (OR: 8.97; CI: 5.56 to 14.45, P<0.01). Surgical treatment for SDAVFs achieves higher rates of complete occlusion and successful treatment compared to endovascular treatment, with lower rates of recurrence, retreatment, and initial treatment failure. Although both treatments show similar improvements in neurological status and periprocedural complications, surgery remains the preferred approach for definitive results. Treatment decisions should be individualized based on patient-specific factors and anatomical characteristics. Further research is needed to confirm these results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wk_sea完成签到,获得积分10
刚刚
1秒前
2秒前
orixero应助浊人采纳,获得10
2秒前
2秒前
柚子应助sunwei采纳,获得10
3秒前
胡呼呼完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
Lynn发布了新的文献求助10
4秒前
envy完成签到,获得积分10
4秒前
poohpooh发布了新的文献求助10
4秒前
chaoqi完成签到,获得积分10
5秒前
直率的雪晴完成签到,获得积分10
5秒前
灵宝宝完成签到,获得积分10
6秒前
打打应助落寞依珊采纳,获得10
6秒前
科研通AI5应助蓝蓝的腿毛采纳,获得30
6秒前
lieditongxu完成签到,获得积分10
7秒前
7秒前
科研通AI2S应助莫小乔斯采纳,获得10
8秒前
尊敬乐蕊完成签到,获得积分10
8秒前
英格雷西发布了新的文献求助10
8秒前
8秒前
8秒前
小瑞发布了新的文献求助10
9秒前
yyds完成签到,获得积分0
9秒前
lieditongxu发布了新的文献求助10
9秒前
9秒前
丘比特应助科研通管家采纳,获得10
10秒前
大个应助科研通管家采纳,获得30
10秒前
YOYOYO应助科研通管家采纳,获得20
10秒前
10秒前
Hello应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得10
10秒前
yoyo完成签到,获得积分10
10秒前
充电宝应助科研通管家采纳,获得10
10秒前
JamesPei应助科研通管家采纳,获得10
10秒前
10秒前
高分求助中
Les Mantodea de Guyane Insecta, Polyneoptera 2500
Technologies supporting mass customization of apparel: A pilot project 450
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 430
Tip60 complex regulates eggshell formation and oviposition in the white-backed planthopper, providing effective targets for pest control 400
A Field Guide to the Amphibians and Reptiles of Madagascar - Frank Glaw and Miguel Vences - 3rd Edition 400
China Gadabouts: New Frontiers of Humanitarian Nursing, 1941–51 400
The Healthy Socialist Life in Maoist China, 1949–1980 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3790371
求助须知:如何正确求助?哪些是违规求助? 3335077
关于积分的说明 10273337
捐赠科研通 3051539
什么是DOI,文献DOI怎么找? 1674723
邀请新用户注册赠送积分活动 802757
科研通“疑难数据库(出版商)”最低求助积分说明 760853